In their impressive meta-analysis, Cheng and colleagues find no meaningful evidence for the impact of psychosocial interventions that […]
The effect of the prescription opioid crisis in North America is well documented.1 In 2018 some 68 500 […]
Reminisce about good timesHelen Garr, deputy director of NHS Practitioner Health, says, “Many of us will be greeting […]
Key focus of the deal is focal-onset seizure treatment cenobamate
Company is aiming for approval in the adjuvant setting
The total value of all payments for the Atacand brand is $400m
New Innovative Licensing and Access Pathway launched
Updated Date: Mon, 28 Dec 2020 00:00:00 EST
Updated Date: Mon, 28 Dec 2020 00:00:00 EST
